Page 1

IDEXX Q3 2021 Earnings Highlights ( NASDAQ : IDXX ) Operating Profit $ 226M Revenue $ 810M Reported growth : Organic growth : CAG Diagnostics Recurring Organic Growth : CAG Revenue Reported growth : Organic growth : Net CAG Revenue CAG Diagnostics Recurring IDEXX VetLab® Consumables $ 732M + 15 % + 13 % Rapid Assay Products Reference Laboratory Dx and Consulting Services + 12 % + 10 % ÇAG Diagnostics Services and Accessories CAG Diagnostics Capital - Instruments Veterinary Software , Services and Diagnostic Imaging Systems + 11 % Q3 Revenue $ 638M $ 253M $ 77M $ 282M $ 26M $ 39M $ 55M O IDEXX Premium Instruments Catalyst Installed Base ( in thousands ) + 14 % year over year 31.132.8 35.1 37.038.5 39.841.5 43.945.146.0 47.649.6510 526 54.3 27.9 % of Revenue YoY change in basis points : Reported Comparable Revenue Reported growth : Organic growth : Reported Growth year over year + 13 % + 16 % + 9 % + 11 % + 10 % + 34 % Water + 33 % +410 bps +20 bps Organic Growth year over year + 11 % $ 38M + 15 % + 13 % + 14 % + 9 % + 10 % + 9 % + 33 % + 15 % Installed Base Premium Hematology Installed Base ( in thousands ) 41 TOTAL Diluted Earnings Per Share $ 2.03 + 9 % year over year 26.7274 28028.9 29.529.8 30.5 315 320 32.433.6 34.635.135.836.8 Reported growth : Comparable growth : Q3 Premium Instrument Placements Catalyst New and competitive Premium Hematology SediVue® Dx Revenue Reported growth : Organic growth : LPD WW 2,078 1,347 Ⓒ2021 IDEXX Laboratories , Inc. All rights reserved . Contact : John Ravis , Investor Relations ( 207 ) 556-8155 . 1,587 642 4,307 + 20 % + 12 % $ 29M -21 % -23 % North America 792 1,286 344 749 417 SediVue Installed Base ( in thousands ) Intl 1,003 838 225 1,958 2,349 + 25 % year over year 46 5.2 5.9 6.6 7.1 7.6 8.2 8.9 93 96 10.010.7 11.311.912.5 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2018 2019 2020 2021 2018 2019 2020 2021 2018 2019 2020 2021 For full financial data , non - GAAP reconciliations and cautionary language regarding forward - looking statements , please refer to IDEXX's 2021 third quarter earnings release issued on November 2 , 2021 available at https://www.idexx.com/investors . Amounts presented may not recalculate due to rounding . IDEXX